1. Welcome to ODwire.org, the largest and longest-running social network for eye care professionals, with over 20,000 ECP members!

    We offer private peer-to-peer discussions, articles, webinars, podcasts & more!

    Our site is free to all Optometrists, OD Students, Opticians, and Ophthalmologists, and practice administrators. Join us!

  2. *** CEwire2020 will be online LIVE on June 27 & 28
    63 LIVE COPE-Approved Credits! [REGISTER HERE] [COURSE SCHEDULE]
    Dismiss Notice

Dynamic Developments in AMD Dx and Tx The Dawn of Pharmaco-Genetics (44981-PS )

Discussion in 'CEwire2015' started by AdminWolf, May 20, 2015.

  1. AdminWolf

    AdminWolf Site Administrator & Tech Lead
    Staff Member

    14,421
    Messages
    Joined:
    Feb 24, 2001
    School/Org:
    University of Michigan Medical School
    City:
    Lake Oswego
    State:
    OR
    Lecturer: @Jerome Sherman

    Synopsis:
    AMD is the most common etiology of vision loss in the US. AREDS 12 confirm that anti-oxidants and zinc can reduce the risk of progressing from Category 3 AMD to more serious vision loss by about 25.

    However, based upon a landmark study published in Aug 2013 in the journal Ophthalmology, the presence or absence of high risk alleles in CFH and ARMS2 genes determines the most effective nutraceuticals for each patient.


    Register for CEwire2015
    to watch the recorded lecture & get CE credit through August 17, 2015.

    Discuss the lecture and ask questions in the thread below.